Care Pathway of RPE65-Related Inherited Retinal Disorders from Early Symptoms to Genetic Counseling: A Multicenter Narrative Medicine Project in Italy

References

• Ziccardi L, Cordeddu V, Gaddini L, et al. Gene therapy in retinal dystrophies. In J Mol Sci. 2019;20(22):5722. doi:10.3390/ijms20225722
   Web of Science ®Google Scholar
• Broadgate S, Yu J, Downes SM, Halford S. Unravelling the genetics of inherited retinal dystrophies: past, present and future. Prog Retin Eye Res. 2017;59:53–96. doi:10.1016/j.preteyeres.2017.03.003
   PubMed Web of Science ®Google Scholar
• Kang C, Scoo LJ. Voretigene neparvovec: a review in RPE65 mutation-associated inherited retinal dystrophy. Mol Diagn Ther. 2020;24(4):487–495. doi:10.1007/s40291-020-00475-6
   PubMed Web of Science ®Google Scholar
• Duncan JL, Pierce A, Laster AM, et al. Inherited retinal degenerations: current landscape and knowledge gaps. Transl Vis Sci Technol. 2018;7(4):6. doi:10.1167/tvst.7.4.6
   PubMed Web of Science ®Google Scholar
• Verbakel SK, van Huet RAC, Boon CJF, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res. 2018;66:157–186. doi:10.1016/j.preteyeres.2018.03.005
   PubMed Web of Science ®Google Scholar
• Kondkar AA, Abu-Amero KK. Leber congenital amaurosis: current genetic basis, scope for genetic testing and personalized medicine. Exp Eye Res. 2019;189:107834. doi:10.1016/j.exer.2019.107834
   Web of Science ®Google Scholar
• Prokofyeva E, Troeger E, Wilke R, Zrenner E. Early visual symptom patterns in inherited retinal dystrophies. Ophthalmologica. 2011;226(3):151–156. doi:10.1159/000330381
   Web of Science ®Google Scholar
• Jacobson SG, Aleman T, Cideciyan AV, et al. Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci. 2009;50(5):2368–2375. doi:10.1167/iovs.08-2696
   PubMed Web of Science ®Google Scholar
• Russell SR, Bennet J, Wellman JA, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, Phase 3 trial. Lancet. 2017;390(10097):849–860. doi:10.1016/S0140-6736(17)31868-8
   PubMed Web of Science ®Google Scholar
• Russell SR, Maguire AM, Bennett J, et al. Visual function questionnaire responses in the voretigene neparvovec phase 3 trial. Invest Ophthalmol Vis Sci. 2019;60(9):4968.
   Web of Science ®Google Scholar
• Hafler BP. Clinical progress in inherited retinal degenerations: gene therapy clinical trials and advances in genetic sequencing. Retina. 2017;37(3):417–423. doi:10.1097/IAE.0000000000001341
   PubMed Web of Science ®Google Scholar
• Thompson DA, Ali RR, Banin E, et al. Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the monaciano symposium. Invest Ophthalmol Vis Sci. 2015;56(2):918–931. doi:10.1167/iovs.14-16049
   PubMed Web of Science ®Google Scholar
• Lorenz B, Tavares J, van den Born LI, Marques JP, Scholl HPN; EVICR. net Group. Current management of patients with RPE65 mutation-associated inherited retinal degenerations (IRDs) in Europe. Results of a multinational survey by the European Vision Institute Clinical Research Network EVICR.net. Ophthalmic Res. 2021;64(5):740–753. doi:10.1159/000515688
   Web of Science ®Google Scholar
• Kurent A, Stirn-Kranjc B, Brecelj J. Electroretinographic characteristics in children with infantile nystagmus syndrome and early-onset retinal dystrophies. Eur J Ophthalmol. 2015;25(1):33–42. doi:10.5301/ejo.5000493
   Web of Science ®Google Scholar
• Suppiej A, Marino S, Reffo ME, et al. Early onset retinal dystrophies: clinical clues to diagnosis for pediatricians. Ital J Pediatr. 2019;45(1):168. doi:10.1186/s13052-019-0760-5
   Web of Science ®Google Scholar
• Mühlfriedel R, Sothilingam V, Tanimoto N, Seeliger MW. Gene replacement therapy for inherited retinal dystrophies. Klin Monbl Augenheilkd. 2017;234(3):320–328. doi:10.1055/s-0043-101817
   Web of Science ®Google Scholar
• Sodi A, Banfi S, Testa F, et al; Italian IRD Working Group. RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy. Orphanet J Rare Dis. 2021;16(1):257. doi:10.1186/s13023-021-01868-4
   PubMed Web of Science ®Google Scholar
• Parmeggiani F, Sato G, De Nadai K, Romano MR, Binotto A, Costagliola C. Clinical and rehabilitative management of retinitis pigmentosa: up-to-date. Curr Genomics. 2011;12(4):250–259. doi:10.2174/138920211795860125
   PubMed Web of Science ®Google Scholar
• Patel U, Boucher M, de Léséleuc L, Visintini S. Voretigene neparvovec: an emerging gene therapy for the treatment of inherited blindness. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; Mar 1, 2018:2016–2169.
   Google Scholar
• Herse P. Retinitis pigmentosa: visual function and multidisciplinary management. Clin Exp Optom. 2005;88(5):335–350. doi:10.1111/j.1444-0938.2005.tb06717.x
   PubMedGoogle Scholar
• Gualandi R, Masella C, Viglione D, Tartaglini D, Frey R. Exploring the hospital patient journey: what does the patient experience? PLoS One. 2019;14(12):e0224899. doi:10.1371/journal.pone.0224899
   PubMed Web of Science ®Google Scholar
• Greenhalgh T. Cultural contexts of health: the use of narrative research in the health sector. Copenhagen: WHO Regional Office for Europe; 2016. Health Evidence Network (HEN) synthesis report 49. Available from: http://www.euro.who.int/__data/assets/pdf_file/0004/317623/HEN-synthesis-report-49.pdf. Accessed March 23, 2021.
   Google Scholar
• Pierret J. The illness experience: state of knowledge and perspectives for research. Sociol Health Illn. 2003;25:4–22. doi:10.1111/1467-9566.t01-1-00337
   PubMed Web of Science ®Google Scholar
• Ragusa L, Crinò A, Grugni G, Reale L, Fiorencis A, Licenziati MR. Caring and living with Prader-Willi syndrome in Italy: integrating children, adults and parents’ experiences through a multicentre narrative medicine research. BMJ Open. 2020;10(8):e036502. doi:10.1136/bmjopen-2019-036502
   PubMed Web of Science ®Google Scholar
• Tonini MC, Fiorencis A, Iannacchero R, et al. Narrative medicine to integrate patients’, caregivers’ and clinicians’ migraine experiences: the DRONE multicentre project. Neurol Sci. 2021;15:1–12.
   Google Scholar
• Marini MG. Narrative Medicine: Bridging the Gap Between Evidence-Based Care and Medical Humanities. London: Springer International Publishing; 2016.
   Google Scholar
• Kleinman A. The Illness Narrative, Suffering and Healing the Human Condition. New York: Basic Book; 1989.
   Google Scholar
• Greenhalgh T, Hurwitz B. Narrative based medicine: why study narrative? BMJ. 1999;318(7175):48–50. doi:10.1136/bmj.318.7175.48
   PubMed Web of Science ®Google Scholar
• Midena E, Varano M, Pilotto E, et al. Real-life patient journey in neovascular age-related macular degeneration: a narrative medicine analysis in the Italian setting. Eye. 2021. doi:10.1038/s41433-021-01470-9
   Web of Science ®Google Scholar
• Fioretti C, Mazzocco K, Riva S, Oliveri S, Masiero M, Pravettoni G. Research studies on patients’ illness experience using the narrative medicine approach: a systematic review. BMJ Open. 2016;6(7):e011220. doi:10.1136/bmjopen-2016-011220
   PubMed Web of Science ®Google Scholar
• Marini MG. Languages of Care in Narrative Medicine. Words, Space and Time in the Healthcare Ecosystem. London: Springer International Publishing; 2019.
   Google Scholar
• Nowaczyk MJ. Narrative medicine in clinical genetics practice. Am J Med Genet A. 2012;158A(8):1941–1947. doi:10.1002/ajmg.a.35482
   Web of Science ®Google Scholar
• Web Content Accessibility Guidelines (WCAG) 2.1. W3C Recommendations; June 05, 2018. Available from: https://www.w3.org/TR/WCAG21/. Accessed March 23, 2021.
   Google Scholar
• Reid K, Soundy A. A qualitative study examining the illness narrative master plots of people with head and neck cancer. Behav Sci. 2019;9(10):110. doi:10.3390/bs9100110
   Google Scholar
• Peeters B, Marini M. Narrative medicine across languages and cultures: using minimal English for increased comparability of patients’ narratives. In: Goddard C, editor. Minimal English for a Global World: Improved Communication Using Fewer Words. Basingstoke, UK: Palgrave Macmillan; 2018:259–286.
   Google Scholar
• Charon R. The patient-physician relationship. Narrative Medicine: a model for empathy, reflection, profession, and trust. JAMA. 2001;286(15):1897–1902. doi:10.1001/jama.286.15.1897
   PubMed Web of Science ®Google Scholar
• Banfi P, Cappuccio A, Latella ME, et al. Narrative medicine to improve the management and quality of life of patients with COPD: the first experience applying parallel chart in Italy. Int J Chron Obstruct Pulmon Dis. 2018;13:287–297. doi:10.2147/COPD.S148685
   PubMed Web of Science ®Google Scholar
• Brédart A, Marrel A, Abetz-Webb L, Lasch K, Acquadro C. Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience. Health Qual Life Outcomes. 2014;5(12):15. doi:10.1186/1477-7525-12-15
   Web of Science ®Google Scholar
• Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data and repealing Directive 95/46/EC (General Data Protection Regulation. Published on the Official Journal of the European Union L 119; May 4, 2016. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R0679. Accessed March 23, 2021.
   Google Scholar
• Personal data code protection. Legislat. Decree no. 196 of 30 June 2003. Published on the Italian Official Journal n. 174. Supplementary n. 123; July 29, 2003. Available from: https://www.camera.it/parlam/leggi/deleghe/Testi/03196dl.htm. Accessed March 23, 2021.
   Google Scholar
• Bazeley P, Jackson K. Qualitative Data Analysis with NVivo. London: SAGE; 2013.
   Google Scholar
• Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:6. doi:10.1093/intqhc/mzm042
   Web of Science ®Google Scholar
• Thurston M, Thurston A, McLeod J. Socio-emotional effects of the transition from sight to blindness. Br J Vis Impair. 2010;28(2):90–112. doi:10.1177/0264619609359304
   Google Scholar
• Bittner AK, Edwards L, George M. Coping strategies to manage stress related to vision loss and fluctuations in retinitis pigmentosa. Optometry. 2010;81(9):461–468. doi:10.1016/j.optm.2010.03.006
   PubMedGoogle Scholar
• American Academy of Ophthalmology. Clinical statement: recommendations on clinical assessment of patients with inherited retinal degenerations; 2016. Available from: https://www.aao.org. Accessed May 10, 2021.
   Google Scholar
• Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol. 2007;125(2):151–158. doi:10.1001/archopht.125.2.151
   PubMedGoogle Scholar
• Garip G, Kamal A. Systematic review and meta-synthesis of coping with retinitis pigmentosa: implications for improving quality of life. BMC Ophthalmol. 2019;19(1):181. doi:10.1186/s12886-019-1169-z
   PubMed Web of Science ®Google Scholar
• University of Campania “Luigi Vanvitelli”, Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene (RPE65-NHS), Identifier NCT04525261, https://clinicaltrials.gov/ct2/show/NCT04525261, last accessed on November 25, 2021
   Google Scholar